Abstract:ETHNOPHARMACOLOGICAL RELEVANCE: Tripterygium wilfordii Hook. f. (Tripterygium wilfordii), also known as Huangteng and gelsemium elegan, is a traditional Chinese medicine that has been marketed in China as Tripterygium wilfordii glycoside tablets. Triptolide (TP), an active component in Tripterygium wilfordii extracts, has been used to treat various diseases, including lupus, cancer, rheumatoid arthritis and nephritic syndrome. This review summarizes recent developments in the research on the pharmacodynamics, pharmacokinetics, pharmacy and toxicology of TP, with a focus on its novel mechanism of reducing toxicity. This review provides insight for future studies on traditional Chinese medicine, a field that is both historically and currently important.MATERIALS AND METHODS: We included studies published primarily within the last five years that were available in online academic databases (e.g., PubMed, Google Scholar, CNKI, SciFinder and Web of Science).RESULTS: TP has a long history of use in China because it displays multiple pharmacological activities, including anti-rheumatism, anti-inflammatory, anti-tumor and neuroprotective properties. It has been widely used for the treatment of various diseases, such as rheumatoid arthritis, nephritic syndrome, lupus, Behcet׳s disease and central nervous system diseases. Recently, numerous breakthroughs have been made in our understanding of the pharmacological efficacy of TP. Although TP has been marketed as a traditional Chinese medicine, its multi-organ toxicity prevents it from being widely used in clinical practice.CONCLUSIONS: Triptolide, a biologically active natural product extracted from the root of Tripterygium wilfordii, has shown promising pharmacological effects, particularly as an anti-tumor agent. Currently, in anti-cancer research, more effort should be devoted to investigating effective anti-tumor targets and confirming the anti-tumor spectrum and clinical indications of novel anti-tumor pro-drugs. To apply TP appropriately, with high efficacy and low toxicity, the safety and non-toxic dose range for specific target organs and diseases should be determined, the altered pathways and mechanisms of exposure need to be clarified, and an early warning system for toxicity needs to be established. With further in-depth study of the efficacy and toxicity of TP, we believe that TP will become a promising multi-use drug with improved clinical efficacy and safety in the future.

Triptolide: structural modifications, structure-activity relationships, bioactivities, clinical development and mechanisms.

Triptolide: pharmacological spectrum, biosynthesis, chemical synthesis and derivatives

A Mechanistic Overview of Triptolide and Celastrol, Natural Products from Tripterygium wilfordii Hook F

Triptolide: Medicinal chemistry, chemical biology and clinical progress

Triptolide: reflections on two decades of research and prospects for the future

Athletic activity and hormone concentrations in high school female athletes.

Recent advances in the pharmacological applications and liver toxicity of triptolide

Triptolide: Progress on research in pharmacodynamics and toxicology

Advanced progress of main pharmacology activities of triptolide

Terpenoids from Tripterygium Wilfordii

Antitumor mechanisms and future clinical applications of the natural product triptolide

The Yin and Yang of the Natural Product Triptolide and Its Interactions with XPB, an Essential Protein for Gene Expression and DNA Repair

MicroRNAs as crucial mediators in the pharmacological activities of triptolide (Review)

[Structure Modification of Triptolide, a Diterpenoid from Tripterygium Wilfordii].

Medicinal chemistry and pharmacology of genus Tripterygium (Celastraceae)

Therapeutic potential of triptolide in autoimmune diseases and strategies to reduce its toxicity

The Study of Cellular Mechanism of Triptolide in the Treatment of Cancer, Bone Loss and Cardiovascular Disease and Triptolide's Toxicity

Synthesis and SAR Study of Novel Amidino 2-substituted Benzimidazoles as Potential Antibacterial Agents

Broad targeting of triptolide to resistance and sensitization for cancer therapy

[Congenitally absent pulmonary valve--analysis of ten prenatally diagnosed cases and review of the literature].

Friend or foe? The dual role of triptolide in the liver, kidney, and heart